ONCODESIGN PRECISION MEDICINE S.A. | WebDisclosure

Basculer en Français

9475	Companies
185441	Keywords
117777	Articles
99294	Press releases

Headlines Articles Press releases ONCODESIGN PRECISION MEDICINE S.A.

Home
Companies
ONCODESIGN PRECISION MEDICINE S.A.

PRESS RELEASE

published on 03/05/2025 at 15:52, 8 months 30 days ago

Nomination of Christophe Thurieau as an Independent Member of OPM Board of Directors
Oncodesign Precision Medicine appoints Christophe Thurieau, Executive Director Research at Servier, as an independent member of the Board of Directors for a four-year term. Thurieau brings over 35 years of healthcare expertise to OPM

Board Of Directors Healthcare Christophe Thurieau Oncodesign Precision Medicine Servier
BRIEF

published on 03/05/2025 at 15:52, 8 months 30 days ago

Christophe Thurieau rejoint le Conseil d'Administration d'Oncodesign Precision Medicine

Biotechnologie Conseil D'administration Nomination Christophe Thurieau Oncodesign Precision Medicine
BRIEF

published on 03/05/2025 at 15:52, 8 months 30 days ago

Christophe Thurieau joins the Board of Directors of Oncodesign Precision Medicine

Board Of Directors Biotechnology Appointment Christophe Thurieau Oncodesign Precision Medicine
PRESS RELEASE

published on 03/05/2025 at 15:47, 8 months 30 days ago

Nomination of Christophe Thurieau as an Independent Member of OPM Board of Directors
Nomination de Christophe Thurieau en tant qu’administrateur indépendant du Conseil d’Administration d’OPM. Christophe Thurieau, expert en Recherche et Développement Pharmaceutique, rejoindra OPM pour un mandat de 4 ans

Biopharmaceutique Médecine De Précision Administrateur Indépendant OPM Christophe Thurieau
BRIEF

published on 10/15/2024 at 08:05, 1 year 1 month ago

OPM-101 Phase 1 Trial Results Presented at UEG Week 2024

Ulcerative Colitis Phase 1 Trial UEG Week 2024 OPM-101 Safety Profile
BRIEF

published on 10/15/2024 at 08:05, 1 year 1 month ago

Résultats de l'essai de phase 1 OPM-101 présentés à l'UEG Week 2024

Rectocolite Hémorragique Semaine UEG 2024 OPM-101 Essai De Phase 1 Profil De Sécurité
PRESS RELEASE

published on 10/15/2024 at 08:00, 1 year 1 month ago

Inside Information / Other news releases
OPM presents safety & efficacy data on OPM-101, a novel RIPK2 kinase inhibitor, in healthy volunteers at UEG Week 2024 conference, targeting IBD treatment

Precision Medicine UEG Week 2024 OPM-101 RIPK2 Kinase Inhibitor IBD Treatment

Accesswire

Published on 12/05/2025 at 02:35, 8 hours 32 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 8 hours 37 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 10 hours 7 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 12 hours 2 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 12 hours 7 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 10:30, 36 minutes ago

Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 51 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 1 hour 26 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 37 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 2 hours 1 minute ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis

Les Echos

Published on 12/05/2025 at 08:45, 2 hours 22 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 2 hours 22 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 2 hours 24 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 16 hours 52 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 17 hours 7 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE